Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / COM
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
892K
-
Shares change
-
-25.4K
-
Total reported value, excl. options
-
$39.7M
-
Value change
-
-$1.13M
-
Number of buys
-
1
-
Number of sells
-
-11
-
Price
-
$44.54
Significant Holders of NOVOZYMES A S DKK 2.0 - COM as of Q4 2018
12 filings reported holding B798FW902 - NOVOZYMES A S DKK 2.0 - COM as of Q4 2018.
NOVOZYMES A S DKK 2.0 - COM has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 892K shares
.
Largest 10 shareholders include SOMERVILLE KURT F (214K shares), Hemenway Trust Co LLC (179K shares), Kidder Stephen W (107K shares), Broderick Brian C (106K shares), PUZO MICHAEL J (98.8K shares), Page Arthur B (42K shares), Delaney Dennis R (34.4K shares), Notis-McConarty Edward (31.1K shares), Dempze Nancy E (27.1K shares), and Fayerweather Charles (24.3K shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.